Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP3068803

DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    12.11.2014
  • EP published:
    20.1.2021
  • EP application number:
    14810057.1
  • Max expiry date:
    11.11.2034
  • Title:
    DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS

Timeline

Today
12.11.2014EP application
20.1.2021EP Publication

Owner

  • Name:
    Sanofi Biotechnology
  • Address:
    54 rue La Boétie, 75008 Paris, FR
  • Name:
    Regeneron Pharmaceuticals, Inc.
  • Address:
    777 Old Saw Mill River Road, Tarrytown, NY 10591, US

Inventor

  • Name:
    BACCARA-DINET, Marie
  • Address:
    F-75008 Paris, FR
  • Name:
    BESSAC, Laurence
  • Address:
    F-75008 Paris, FR
  • Name:
    HANOTIN, Corinne
  • Address:
    F-75008 Paris, FR
  • Name:
    PORDY, Robert, C.
  • Address:
    Tarrytown, NY 10591, US
  • Name:
    SASIELA, William, J.
  • Address:
    Tarrytown, NY 10591, US
  • Name:
    REY, Jacques
  • Address:
    F-75008 Paris, FR

Priority

  • Number:
    201361902857 P
  • Date:
    12.11.2013
  • Country:
    US
  • Number:
    201461955337 P
  • Date:
    19.3.2014
  • Country:
    US
  • Number:
    14306222
  • Date:
    31.7.2014
  • Country:
    EP

Classification

  • Categories:
    C07K 16/40, A61K 39/395, A61P 3/06

Upload documents